ECOR on Nasdaq
electroCore, Inc.
American electromedical and electrotherapeutic apparatus company.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with Stereotaxis, Inc., PRECISION OPTICS CORPORATION, INC. or IRIDEX CORP, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
86.8%Gross margin3
-41.1%Operating margin3
-43.6%Net margin3
27.2%Revenue growth, 20253
-$8.3MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue10¢$4.2M
- Selling, general and admin90¢$38.2M
- Interest0¢$14.9K
- Income tax0¢$3.0K
Out of $32.0M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net sales | $32.0M | $25.2M |
| Cost of goods sold | $4.2M | $3.8M |
| Gross profit | $27.8M | $21.4M |
| Research and development | $2.7M | $2.4M |
| Selling, general and administrative | $38.2M | $31.2M |
| Total operating expenses | $40.9M | $33.6M |
| Loss from operations | -$13.2M | -$12.2M |
| Interest and other income | -$298.0K | -$572.0K |
| Interest expense | $590.0K | $389.0K |
| Other expense | $518.0K | |
| Total other expense (income) | $810.0K | -$183.0K |
| Loss before income taxes | -$14.0M | -$12.0M |
| (Provision) benefit from income taxes | -$3.0K | $93.0K |
| Net loss | -$14.0M | -$11.9M |
| Net loss per share of common stock - Basic | -$1.65 | -$1.59 |
| Net loss per share of common stock - Diluted | -$1.65 | -$1.59 |
| Weighted average common shares outstanding - Basic | 8.5K shares | 7.5K shares |
| Weighted average common shares outstanding - Diluted | 8.5K shares | 7.5K shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2025-04-30 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $7.0M | $3.7M | ||
| Marketable securities | $4.6M | $8.5M | ||
| Accounts receivable, net | $1.0M | $1.4M | ||
| Inventories | $1.6M | $1.7M | ||
| Prepaid expenses and other current assets | $1.4M | $1.0M | ||
| Total current assets | $15.7M | $16.3M | ||
| Property and equipment, net | $382.0K | $158.0K | ||
| Operating lease right-of-use assets, net | $2.6M | $3.7M | ||
| Other assets, net | $54.0K | $274.0K | ||
| Total assets | $18.7M | $20.5M | ||
| Accounts payable | $2.7M | $1.8M | ||
| Accrued expenses and other current liabilities | $8.3M | $7.0M | ||
| Current portion of operating lease liabilities | $375.0K | $361.0K | ||
| Total current liabilities | $11.3M | $9.2M | ||
| Operating lease liabilities, noncurrent | $2.4M | $3.8M | ||
| Long-term debt | $6.6M | |||
| Total liabilities | $20.4M | $12.9M | ||
| Common Stock, par value $0.001 per share; 500,000,000 shares authorized as of December 31, 2025 and 2024; 8,004,416 shares issued and outstanding at December 31, 2025, and 6,650,854 shares issued and outstanding at December 31, 2024 | $8.0K | $7.0K | ||
| Additional paid-in capital | $189.2M | $184.5M | ||
| Accumulated deficit | -$191.1M | -$177.1M | ||
| Accumulated other comprehensive loss | $99.0K | $114.0K | ||
| Total stockholders equity (deficit) | -$1.7M | $7.5M | $7.4M | |
| Total liabilities and stockholders equity (deficit) | $18.7M | $20.5M | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 500.0M shares | 500.0M shares | ||
| Common stock, shares issued | 8.0M shares | 6.7M shares | ||
| Common stock, shares outstanding | 8.0M shares | 6.7M shares |
| Period ending | 2025-12-31 | 2025-04-30 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $7.0M | $3.7M | ||
| Marketable securities | $4.6M | $8.5M | ||
| Accounts receivable, net | $1.0M | $1.4M | ||
| Inventories | $1.6M | $1.7M | ||
| Prepaid expenses and other current assets | $1.4M | $1.0M | ||
| Total current assets | $15.7M | $16.3M | ||
| Property and equipment, net | $382.0K | $158.0K | ||
| Operating lease right-of-use assets, net | $2.6M | $3.7M | ||
| Other assets, net | $54.0K | $274.0K | ||
| Total assets | $18.7M | $20.5M | ||
| Accounts payable | $2.7M | $1.8M | ||
| Accrued expenses and other current liabilities | $8.3M | $7.0M | ||
| Current portion of operating lease liabilities | $375.0K | $361.0K | ||
| Total current liabilities | $11.3M | $9.2M | ||
| Operating lease liabilities, noncurrent | $2.4M | $3.8M | ||
| Long-term debt | $6.6M | |||
| Total liabilities | $20.4M | $12.9M | ||
| Common Stock, par value $0.001 per share; 500,000,000 shares authorized as of December 31, 2025 and 2024; 8,004,416 shares issued and outstanding at December 31, 2025, and 6,650,854 shares issued and outstanding at December 31, 2024 | $8.0K | $7.0K | ||
| Additional paid-in capital | $189.2M | $184.5M | ||
| Accumulated deficit | -$191.1M | -$177.1M | ||
| Accumulated other comprehensive loss | $99.0K | $114.0K | ||
| Total stockholders equity (deficit) | -$1.7M | $7.5M | $7.4M | |
| Total liabilities and stockholders equity (deficit) | $18.7M | $20.5M | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 500.0M shares | 500.0M shares | ||
| Common stock, shares issued | 8.0M shares | 6.7M shares | ||
| Common stock, shares outstanding | 8.0M shares | 6.7M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$14.0M | -$11.9M |
| Stock based compensation | $1.9M | $1.9M |
| Depreciation and amortization | $501.0K | $760.0K |
| Amortization of right of use assets | $1.2M | $498.0K |
| Amortization of debt discount | $135.0K | |
| Write-down of licensed devices | $150.0K | |
| Inventory reserve charge | $41.0K | |
| Increase in provision for credit losses | $523.0K | $51.0K |
| Accounts receivable | -$142.0K | -$710.0K |
| Inventories | $16.0K | $713.0K |
| Prepaid expenses and other assets | -$294.0K | $102.0K |
| Accounts payable | $2.5M | $1.0M |
| Accrued expense and other current liabilities | $635.0K | $831.0K |
| Operating lease liabilities | -$1.3M | -$225.0K |
| Net cash used in operating activities | -$8.2M | -$6.9M |
| Purchase of property and equipment | -$66.0K | |
| Sale (purchase) of marketable securities | $3.9M | -$8.5M |
| Net cash provided by (used in) investing activities | $3.9M | -$8.5M |
| Sale of common stock and warrants | $217.0K | $8.3M |
| Issuance of long-term debt | $7.5M | |
| Debt issuance costs | -$95.0K | |
| Equity issuance costs | -$94.0K | -$232.0K |
| Proceeds from exercise of options | $98.0K | |
| Proceeds from exercise of warrants | $1.0K | $371.0K |
| Net cash provided by financing activities | $7.6M | $8.4M |
| Effect of changes in exchange rates on cash and cash equivalents | $18.0K | $147.0K |
| Net decrease in cash and cash equivalents | $3.3M | -$6.9M |
| Proceeds from sale of state net operating losses | $48.0K | $122.0K |
| Interest paid | $397.0K | $13.0K |
| Insurance premium financing | $452.0K | $359.0K |
| Accounts payable settled through common stock and warrants | $1.9M | $1.0M |
| Accounts payable settled through the exercise of warrants | $495.0K | $495.0K |
| Non-cash debt issuance costs | $213.0K | |
| Shares issued in connection with Avenue loan | $720.0K | |
| Accrued purchases of property and equipment | $203.0K | |
| Right-of-use asset and operating lease liability | $3.3M |
No quarter-by-quarter statement was filed.
Leadership
Who has led electroCore, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
20202025
- Chief executive officerDaniel S. Goldberger Oct 3, 2019 to now11
- Chief executive officerFrancis R. Amato Jun 21, 2018 to Jun 11, 201912
- PresidentJoshua S. Lev Apr 1, 2026 to now13
- Chief financial officerJoshua S. Lev Oct 4, 2024 to now14
- Chief financial officerBrian M. Posner Apr 3, 2019 to Jan 17, 202415
- Chief financial officerGlenn S. Vraniak Jun 21, 2018 to Mar 26, 201916
Board members and other officers (20)
- OfficerJoshua S. Lev Sep 10, 2026 to now17
- Chief Science/Strategy OfficerJoseph P. Errico Jun 21, 2018 to Apr 12, 201918
- Chief Medical OfficerPeter S. Staats Jun 21, 2018 to Apr 1, 201919
- Board memberJames Charles Theofilos Aug 5, 2025 to now20
- Board memberElena Bonfiglioli Sep 12, 2025 to now21
- Board memberCharles Steve Theofilos Dec 18, 2023 to Sep 5, 202422
- Board memberJulie Ann Goldstein Mar 16, 2022 to now23
- Board memberPatricia Wilber Mar 16, 2022 to now24
- Board memberF. Peter Cuneo Apr 6, 2020 to Sep 5, 202425
- Board memberThomas M. Patton Apr 6, 2020 to now26
- Board memberDaniel S. Goldberger Oct 3, 2019 to now11
- Board memberCarrie Cox Jun 21, 2018 to Jun 11, 201927
- Board memberFrancis R. Amato Jun 21, 2018 to Jun 11, 201912
- Board memberJames L. L. Tullis Jun 21, 2018 to Apr 16, 202028
- Board memberJoseph P. Errico Jun 21, 2018 to Dec 15, 202218
- Board memberMichael G. Atieh Jun 21, 2018 to Jun 15, 202129
- Board memberNicholas Colucci Jun 21, 2018 to Jun 11, 201930
- Board memberStephen Ondra Jun 21, 2018 to Jun 15, 202131
- Board memberThomas J. Errico Jun 21, 2018 to now32
- Board memberTrevor J. Moody Jun 21, 2018 to Aug 4, 202333
Former names
- ElectroCore, LLCNov 26, 2012 to Jun 20, 20182
Timeline
Filings
281 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 59 major events, 123 insider forms, 17 large holders, 11 private raises, 49 other. The latest 20:
- Sep 22, 20264 EDGAR
- Sep 18, 20264/A EDGAR
- Sep 14, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20264 EDGAR
- Sep 9, 20268-K EDGAR
- Aug 25, 20264 EDGAR
- Aug 17, 20264 EDGAR
- Aug 13, 2026SCHEDULE 13G/A EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 20, 2026DEF 14A EDGAR
- Jun 12, 20264 PRIMARY DOCUMENT EDGAR
- May 29, 20264 EDGAR
The 281 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 17 such filings since October 2021, the latest 10:
- Aug 13, 2026SCHEDULE 13G/A
- May 5, 2026SCHEDULE 13G
- Nov 13, 2025SCHEDULE 13G/A
- Sep 8, 2025SCHEDULE 13G
- Jul 9, 2025SCHEDULE 13G/A
- Jun 5, 2025SCHEDULE 13G
- May 14, 2025SCHEDULE 13D
- May 14, 2025SCHEDULE 13D/A
- Mar 24, 2025SCHEDULE 13G/A
- Jun 7, 2024SC 13D/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Money raised
Private offerings the company reported to the SEC on Form D.
- Apr 1, 2026Filed a private offering of securities Form D: named in the filing: Thomas M. Patton, John P. Gandolfo, Michael C. Fox, Joshua Lev, Elena C. Bonfiglioli, Julie Ann Goldstein Form D
- Oct 6, 2025Filed a private offering of securities Form D: named in the filing: Patricia Ann Wilber, Daniel S. Goldberger, Julie Ann Goldstein, Joshua S. Lev, Thomas J. Errico, Elena C. Bonfiglioli Form D
- Oct 2, 2025Raised $1.9 million in a private offering of equity Form D: 3 investors so far Form D
- Sep 10, 2025Filed a private offering of securities Form D: named in the filing: Joshua S. Lev, Patricia Ann Wilber, John P. Gandolfo, Thomas M. Patton, Julie Ann Goldstein, James C. Theofilos Form D
- Nov 11, 2024Filed a private offering of securities Form D: named in the filing: Thomas M. Patton, Peter P. Cuneo, Charles S. Theofilos, Daniel S. Goldberger, John P. Gandolfo, Joshua S. Lev Form D
- Aug 1, 2024Filed a private offering of securities Form D: named in the filing: Peter P. Cuneo, Brian S. Posner, Julie A. Goldstein, Thomas M. Patton, Daniel S. Goldberger, Thomas J. Errico Form D
- Jun 5, 2024Raised $7.8 million in a private offering of equity Form D: 13 investors so far Form D
- May 1, 2024Filed a private offering of securities Form D: named in the filing: Brian S. Posner, Peter P. Cuneo, Daniel S. Goldberger, John P. Gandolfo, Thomas J. Errico, Charles S. Theofilos Form D
- Aug 2, 2023Raised $52,372 in a private offering of equity Form D: 7 investors so far Form D
- Aug 2, 2023Raised $750,000 in a private offering of equity Form D: 6 investors so far Form D
- Sep 20, 2021Raised $192,000 in a private offering of equity Form D: named in the filing: Stephen J. Ondra, Daniel S. Goldberger, Michael G. Atieh, Peter G. Cuneo, Thomas M. Patton, Brian S. Posner Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 32. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARJoshua S. Lev, President
- 14
- 15
- 16
- 17SEC EDGARJoshua S. Lev, Officer
- 18
- 19
- 20
- 21SEC EDGARElena Bonfiglioli, Board member
- 22
- 23SEC EDGARJulie Ann Goldstein, Board member
- 24SEC EDGARPatricia Wilber, Board member
- 25SEC EDGARF. Peter Cuneo, Board member
- 26SEC EDGARThomas M. Patton, Board member
- 27SEC EDGARCarrie Cox, Board member
- 28SEC EDGARJames L. L. Tullis, Board member
- 29SEC EDGARMichael G. Atieh, Board member
- 30SEC EDGARNicholas Colucci, Board member
- 31SEC EDGARStephen Ondra, Board member
- 32SEC EDGARThomas J. Errico, Board member
- 33SEC EDGARTrevor J. Moody, Board member